Results 61 to 70 of about 8,860 (153)

Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat

HIV Research & Clinical Practice, 2019
Background and objectives: Access to safe and reliable contraception in the context of ARVs is essential. This study aimed to investigate the steady-state pharmacokinetics (PK) of ethinylestradiol/levonorgestrel (EE/LNG) 30/150 μg (Microgynon®) and ...
Emilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, Saye Khoo, Nneka Nwokolo, Marta Boffito   +5 more
doaj   +1 more source

Recent Approaches for the Synthesis of Pyridine and Quinoline Cores Present in Natural Products

Advanced Synthesis &Catalysis, Volume 368, Issue 10, 19 May 2026.
An anthology of the most recent methods used to synthesize pyridines and quinolines found in natural products over the last decade. Pyridines, quinolines, and their derivatives represent a class of significant heterocyclic compounds that are prevalent in a multitude of natural products, including alkaloids found in plants, fungi, insects, marine ...
Carl Bowman, Mathieu Frenette, Sylvain Canesi   +2 more
wiley   +1 more source

This Is Not a Myeloproliferative Neoplasm…

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley   +1 more source

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

BMC Infectious Diseases, 2019
Background Direct comparisons between lamivudine plus bPIs and lamivudine plus dolutegravir as maintenance strategies in virologically-suppressed HIV positive patients are lacking.
Alberto Borghetti, Francesca Lombardi, Roberta Gagliardini, Gianmaria Baldin, Arturo Ciccullo, Davide Moschese, Arianna Emiliozzi, Simone Belmonti, Silvia Lamonica, Francesca Montagnani, Elena Visconti, Andrea De Luca, Simona Di Giambenedetto   +12 more
doaj   +1 more source

Enhancement of flow properties, solubility, and dissolution of the atazanavir by spherical crystallization

Journal of Applied Pharmaceutical Research
Background: The present work aimed to develop spherical agglomerates of Atazanavir (ATZR) with enhanced flow properties, compressibility, solubility, and dissolution. 22 full factorial design approach was employed to develop agglomerates.
Ashok T Jadhav, Sanjay S. Pekamwar
doaj   +1 more source

Results of a comparative study of the efficacy of once daily darunavir/atazanavir in treatment-naïve patients with HIV infection

Терапевтический архив, 2014
AIM. To evaluate the efficacy of boosted darunavir and atazanavir used in antiretroviral therapy (ARVT) regimens for treatment-naïve HIV-infected patients with low baseline immune parameters and a high viral load. MATERIALS AND METHODS. The investigators
G F Moshkovich, S V Minaeva
doaj  

A Validated RP-HPLC Method for the Determination of Atazanavir in Pharmaceutical Dosage Form

E-Journal of Chemistry, 2011
A validated RP HPLC method for the estimation of atazanavir in capsule dosage form on YMC ODS 150 × 4.6 mm, 5 μ column using mobile phase composition of ammonium dihydrogen phosphate buffer (pH 2.5) with acetonitrile (55:45 v/v). Flow rate was maintained
K. Srinivasu, J. Venkateswara Rao, N. Appala Raju, K. Mukkanti   +3 more
doaj   +1 more source

Breastmilk transfer and infant exposure to atazanavir/ritonavir in breastfeeding women with HIV: results from IMPAACT 2026

Frontiers in Reproductive Health
BackgroundBreastfeeding offers significant health benefits, and guidance for women with HIV increasingly emphasizes individualized, informed infant-feeding decisions. Breastmilk antiretroviral transfer and safety data are needed to inform shared decision-
Emily Anne Barr, Emily Anne Barr, Mauricio Pinilla, Jeremiah D. Momper, Ahizechukwu C. Eke, Lucy Koech, Kristina M. Brooks, Victoria Ndyanabangi, Sandra K. Burchett, Sujith Valiyaparambil, Mark Mirochnick, Mark Mirochnick, Alice Marie Stek, Brookie M. Best, Brookie M. Best, Rachael Jeffrey, Chelsea Stotz, Marije Van Schalkwyk, Renee Browning, David E. Shapiro, Kathleen M. Powis, Kathleen M. Powis   +21 more
doaj   +1 more source

Approaches to antiretroviral therapy in HIV-infected patients with low CD4 lymphocyte counts

Терапевтический архив, 2015
There are increasing numbers of patients with late-stage HIV infection in the Russian Federation. To choose optimal antiretroviral therapy regimens for patients with severe immunosuppression is a relevant problem.
V I Shakhgildyan, M V Yagodkin
doaj  

Atazanavir urolithiasis without recent intake of atazanavir

Annales de Biologie Clinique, 2019
Valery, Brunel, Nathalie, Massy, Benoit, Malval   +2 more
openaire   +3 more sources